Long-form analysis. Written with data. Published with authority.

Cannabis beverages posted 88.2% year-over-year sales growth in New York. Unit sales more than doubled. Tea and coffee exploded at +223.8%. This is not a subcategory trend. It is a consumer behavior shift that will reshape product strategy for every operator in the state.

57% of all New York cannabis licenses were awarded to Social and Economic Equity applicants. A federal court just ruled the constitutional challenge to that framework will proceed. What dormant Commerce Clause doctrine means for state-level cannabis markets nationally.

New York issued 2,204 adult-use licenses. Only 623 dispensaries are operational. The bottleneck has shifted from regulation to execution. Real estate. Capital. Buildout timelines. Section 280E.

Average item prices fell 11.6% in one year. As margins compress, the brands that survive will not be the ones with the most shelf space. They will be the ones with the clearest value proposition.

In 2023, New York had too much product and too few stores. In 2026, demand is outpacing supply. 560 cultivators are licensed. 9.1 million square feet of canopy exists on paper. The CCB is allowing tier upgrades.

Medical cannabis revenue dropped 30% year-over-year. 19 registered organizations are watching their patient base migrate to adult-use. The long-term role of the medical program is undefined.